Downloaded 13 times
Uploaded byNcmf Halal
Fda
This document outlines the FDA's proposed plans and programs for regulating halal products in the Philippines. It discusses establishing a Halal Unit within the FDA to oversee licensing of halal establishments, registration of halal products, and post-market surveillance. Products that would be regulated include food, cosmetics, pharmaceuticals, and medical devices. The FDA plans to coordinate with other agencies like the NCMF and ensure its halal policies are consistent with national standards. Challenges include developing clear interagency policies and regulations on halal as well as expanding laboratory testing capabilities for halal products.
Fda
- 1. FDA Proposed Halal Plans or Program Terms of Reference
- 2. Outline FDAMandate FDA TOR Licensing Registration Post-market Surveillance
- 3. FDA-Regulated Products Processed Food, Food Additives, Food Supplements and other Food Products Cosmetic Products, Tobacco Pharmaceutical Products (Human and Animals, Biological Products) Medical Devices, Radiation-emitting equipment/devices Others – Toys, Urban Pesticides, etc
- 4. FDA Terms ofReference (Halal) Licensing of Establishment Product Registration Post-Market Surveillance
- 5. FDA Initiatives onHalal Creation of Halal Unit To support the Halal industry (for health products) in the country with the other agencies, led by the NCMF To ensure truthfulness of Halal claims in relation to issuance of Licensing of Establishments (LTO), Product Registration (CPR/Product Notification), and Post-market Surveillance of establishments and products (e.g. audits, sampling and testing of products for Halal) To ensure that FDA health product policies or guidelines on Halal are consistent with the Philippine National Standards and national policy on Halal
- 6. Licensing (Health products-Food,Cosmetic, Pharmaceutical and Medical Devices) FDA shall issue LTO to Manufacturers (cGMP) first before the establishment can apply for Halal certification issued by NCMF-accredited Halal Certifying Body (proposal) Consistent with the TESDA plan to conduct Training on Halal, establishments that are Halal-certified shall employ TESDA-trained on Halal personnel
- 7. Registration (Health Products- Food, Cosmetics, Pharmaceuticals and Medical Devices) All Halal label claims shall be substantiated by a Certification/Certificate issued by a Halal-certifying body recognized by NCMF The FDA shall issue specific requirements or guidelines on how the Halal claim shall be substantiated, or to address any gaps fro clarity and consistency with the policies or guidelines NCMF or other agencies. (proposal)
- 8. Post-Market Surveillance (Healthproducts – Food, Cosmetics, Pharmaceuticals) Laboratories engaged in testing health products for Halal shall be required FDA-lab accreditation (RA 9711) Halal laboratory certificates issued by FDA-accredited laboratories or laboratories recognized by the NCMF or Halal-certifying bodies shall be accepted by the FDA for regulatory purposes, e.g. licensing, registration and PMS Develop FDA laboratory to test Halal health products (proposal) to act as a 3rd-party lab for the industry and independent laboratories
- 9. Challenges Clearpolicy, rules and regulations issued by interagency committed on Halal, led by NCMF; FDA Circulars/Memos issued by the FDA shall be subjected to public consultation and public hearing, and the concurrence by the NCMF shall be sought out. There is a Philippine National Standard (PNS) on Halal Food, but no PNS for Cosmetics, Pharmaceutical Products and Medical Devices No application for FDA-accreditation for Halal laboratory (or under scope of test) has yet been received by the FDA. There is a need for capacity building on testing Halal. Coordination with the DA NMIS/BAI in implementing PNS or FDA policies on Halal Food Employment of FDA evaluators, analysts and inspectors, among other personnel, who are Muslim for effective implementation of rules and regulation on Halal
- 10. Thank you forlistening Prepared by: NIDA G. ESCALO, RPH Food-Drug Regulation Officer V Policy and Planning Office For comments or suggestions, please call/email: Phone: (+63) 857 1900 loc 1121 Email: ngescalo@fda.gov.ph